Global AI In Vitro Diagnostic Industry

2023-2029 Global AI In Vitro Diagnostic Industry Research & Trends Analysis Report

Global AI In Vitro Diagnostic Industry

2023-2029 Global AI In Vitro Diagnostic Industry Research & Trends Analysis Report


The research report on ‘AI In Vitro Diagnostic Market’ provides a workplan for stakeholders for the estimated timeframe of 2024-2032. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to the research report, the global market for AI In Vitro Diagnostic should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The global market for in vitro diagnostics (IVD) was growing steadily and was expected to continue its growth in the coming years.

Market Overview: The in vitro diagnostics market involves medical devices, instruments, and reagents used for diagnostic testing of samples such as blood, urine, tissue, and other bodily fluids. AI in vitro diagnostics refers to the integration of artificial intelligence and machine learning technologies into these diagnostic tools and processes.

Growth Drivers: The market for AI in vitro diagnostics has been driven by factors such as increasing demand for personalized medicine, rising prevalence of chronic and infectious diseases, technological advancements in diagnostics, and the need for efficient and accurate diagnostic solutions.

Application Areas: AI has found applications in various areas of in vitro diagnostics, including clinical chemistry, immunoassays, microbiology, hematology, genetic testing, and molecular diagnostics. AI algorithms can aid in data analysis, interpretation, and decision-making, improving the accuracy and efficiency of diagnostic procedures.

This report aims to provide a comprehensive study of the global market for AI In Vitro Diagnostic.
Key Takeaways and Highlights

(1) Global AI In Vitro Diagnostic market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global AI In Vitro Diagnostic market competitive situation, revenue and market share, from 2018 to 2022.

(3) China AI In Vitro Diagnostic market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global AI In Vitro Diagnostic segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global AI In Vitro Diagnostic segment by type and by application and regional segment by type and by application.

(6) AI In Vitro Diagnostic industry supply chain, upstream, midstream and downstream analysis.


Regional Breakdown: Analyzing Market Segments by Geography

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa


Segmenting by Type: Comprehensive Coverage and Analysis

Next-Generation Sequencing Technology

PCR Technology

Chemistry and IA Technology

Pathology Technology


Application-Based Segmentation: Unlocking Market Opportunities

Cancer Diagnostics

Infectious Disease Testing

Metabolic Testing

Cardiac Testing

Diabetes Testing


In the Spotlight: A Closer Look at Market Players

Renalytix

Seegene

Sysmex

PathAI

Prognos

Qiagen

CloudMedX Health

Deepcell

Digital Diagnostics

EKF Diagnostics Holdings

Freenome

GE Healthcare

Glooko

Adaptive Biotechnologies

Aidoc

Anumana

ARUP Laboratories

K Health

Lunit

1 Market Overview

1.1 Product Overview and Scope of AI In Vitro Diagnostic

1.2 Global AI In Vitro Diagnostic Market Size and Forecast

1.3 China AI In Vitro Diagnostic Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China AI In Vitro Diagnostic Share in Global Market, 2018-2029

1.4.2 AI In Vitro Diagnostic Market Size: China VS Global, 2018-2029

1.5 AI In Vitro Diagnostic Market Dynamics

1.5.1 AI In Vitro Diagnostic Market Drivers

1.5.2 AI In Vitro Diagnostic Market Restraints

1.5.3 AI In Vitro Diagnostic Industry Trends

1.5.4 AI In Vitro Diagnostic Industry Policy

2 Global Competitive Situation by Company

2.1 Global AI In Vitro Diagnostic Revenue by Company (2018-2023)

2.2 Global AI In Vitro Diagnostic Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global AI In Vitro Diagnostic Concentration Ratio

2.4 Global AI In Vitro Diagnostic Mergers & Acquisitions, Expansion Plans

2.5 Global AI In Vitro Diagnostic Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China AI In Vitro Diagnostic Revenue by Company (2018-2023)

3.2 China AI In Vitro Diagnostic AI In Vitro Diagnostic Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China AI In Vitro Diagnostic, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 AI In Vitro Diagnostic Industry Chain

4.2 AI In Vitro Diagnostic Upstream Analysis

4.3 AI In Vitro Diagnostic Midstream Analysis

4.4 AI In Vitro Diagnostic Downstream Analysis

5 Sights by Type

5.1 AI In Vitro Diagnostic Classification

5.1.1 Next-Generation Sequencing Technology

5.1.2 PCR Technology

5.1.3 Chemistry and IA Technology

5.1.4 Pathology Technology

5.2 By Type, Global AI In Vitro Diagnostic Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global AI In Vitro Diagnostic Revenue, 2018-2029

6 Sights by Application

6.1 AI In Vitro Diagnostic Segment by Application

6.1.1 Cancer Diagnostics

6.1.2 Infectious Disease Testing

6.1.3 Metabolic Testing

6.1.4 Cardiac Testing

6.1.5 Diabetes Testing

6.2 By Application, Global AI In Vitro Diagnostic Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global AI In Vitro Diagnostic Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global AI In Vitro Diagnostic Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global AI In Vitro Diagnostic Market Size, 2018-2029

7.3 North America

7.3.1 North America AI In Vitro Diagnostic Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America AI In Vitro Diagnostic Market Size Market Share

7.4 Europe

7.4.1 Europe AI In Vitro Diagnostic Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe AI In Vitro Diagnostic Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific AI In Vitro Diagnostic Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific AI In Vitro Diagnostic Market Size Market Share

7.6 South America

7.6.1 South America AI In Vitro Diagnostic Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America AI In Vitro Diagnostic Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global AI In Vitro Diagnostic Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global AI In Vitro Diagnostic Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. AI In Vitro Diagnostic Market Size, 2018-2029

8.3.2 By Company, U.S. AI In Vitro Diagnostic Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe AI In Vitro Diagnostic Market Size, 2018-2029

8.4.2 By Company, Europe AI In Vitro Diagnostic Revenue Market Share, 2018-2023

8.4.3 By Type, Europe AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China AI In Vitro Diagnostic Market Size, 2018-2029

8.5.2 By Company, China AI In Vitro Diagnostic Revenue Market Share, 2018-2023

8.5.3 By Type, China AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan AI In Vitro Diagnostic Market Size, 2018-2029

8.6.2 By Company, Japan AI In Vitro Diagnostic Revenue Market Share, 2018-2023

8.6.3 By Type, Japan AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea AI In Vitro Diagnostic Market Size, 2018-2029

8.7.2 By Company, South Korea AI In Vitro Diagnostic Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia AI In Vitro Diagnostic Market Size, 2018-2029

8.8.2 By Company, Southeast Asia AI In Vitro Diagnostic Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India AI In Vitro Diagnostic Market Size, 2018-2029

8.9.2 By Company, India AI In Vitro Diagnostic Revenue Market Share, 2018-2023

8.9.3 By Type, India AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia AI In Vitro Diagnostic Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia AI In Vitro Diagnostic Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia AI In Vitro Diagnostic Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Renalytix

9.1.1 Renalytix Company Information, Head Office, Market Area and Industry Position

9.1.2 Renalytix Company Profile and Main Business

9.1.3 Renalytix AI In Vitro Diagnostic Models, Specifications and Application

9.1.4 Renalytix AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.1.5 Renalytix Recent Developments

9.2 Seegene

9.2.1 Seegene Company Information, Head Office, Market Area and Industry Position

9.2.2 Seegene Company Profile and Main Business

9.2.3 Seegene AI In Vitro Diagnostic Models, Specifications and Application

9.2.4 Seegene AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.2.5 Seegene Recent Developments

9.3 Sysmex

9.3.1 Sysmex Company Information, Head Office, Market Area and Industry Position

9.3.2 Sysmex Company Profile and Main Business

9.3.3 Sysmex AI In Vitro Diagnostic Models, Specifications and Application

9.3.4 Sysmex AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.3.5 Sysmex Recent Developments

9.4 PathAI

9.4.1 PathAI Company Information, Head Office, Market Area and Industry Position

9.4.2 PathAI Company Profile and Main Business

9.4.3 PathAI AI In Vitro Diagnostic Models, Specifications and Application

9.4.4 PathAI AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.4.5 PathAI Recent Developments

9.5 Prognos

9.5.1 Prognos Company Information, Head Office, Market Area and Industry Position

9.5.2 Prognos Company Profile and Main Business

9.5.3 Prognos AI In Vitro Diagnostic Models, Specifications and Application

9.5.4 Prognos AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.5.5 Prognos Recent Developments

9.6 Qiagen

9.6.1 Qiagen Company Information, Head Office, Market Area and Industry Position

9.6.2 Qiagen Company Profile and Main Business

9.6.3 Qiagen AI In Vitro Diagnostic Models, Specifications and Application

9.6.4 Qiagen AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.6.5 Qiagen Recent Developments

9.7 CloudMedX Health

9.7.1 CloudMedX Health Company Information, Head Office, Market Area and Industry Position

9.7.2 CloudMedX Health Company Profile and Main Business

9.7.3 CloudMedX Health AI In Vitro Diagnostic Models, Specifications and Application

9.7.4 CloudMedX Health AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.7.5 CloudMedX Health Recent Developments

9.8 Deepcell

9.8.1 Deepcell Company Information, Head Office, Market Area and Industry Position

9.8.2 Deepcell Company Profile and Main Business

9.8.3 Deepcell AI In Vitro Diagnostic Models, Specifications and Application

9.8.4 Deepcell AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.8.5 Deepcell Recent Developments

9.9 Digital Diagnostics

9.9.1 Digital Diagnostics Company Information, Head Office, Market Area and Industry Position

9.9.2 Digital Diagnostics Company Profile and Main Business

9.9.3 Digital Diagnostics AI In Vitro Diagnostic Models, Specifications and Application

9.9.4 Digital Diagnostics AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.9.5 Digital Diagnostics Recent Developments

9.10 EKF Diagnostics Holdings

9.10.1 EKF Diagnostics Holdings Company Information, Head Office, Market Area and Industry Position

9.10.2 EKF Diagnostics Holdings Company Profile and Main Business

9.10.3 EKF Diagnostics Holdings AI In Vitro Diagnostic Models, Specifications and Application

9.10.4 EKF Diagnostics Holdings AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.10.5 EKF Diagnostics Holdings Recent Developments

9.11 Freenome

9.11.1 Freenome Company Information, Head Office, Market Area and Industry Position

9.11.2 Freenome Company Profile and Main Business

9.11.3 Freenome AI In Vitro Diagnostic Models, Specifications and Application

9.11.4 Freenome AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.11.5 Freenome Recent Developments

9.12 GE Healthcare

9.12.1 GE Healthcare Company Information, Head Office, Market Area and Industry Position

9.12.2 GE Healthcare Company Profile and Main Business

9.12.3 GE Healthcare AI In Vitro Diagnostic Models, Specifications and Application

9.12.4 GE Healthcare AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.12.5 GE Healthcare Recent Developments

9.13 Glooko

9.13.1 Glooko Company Information, Head Office, Market Area and Industry Position

9.13.2 Glooko Company Profile and Main Business

9.13.3 Glooko AI In Vitro Diagnostic Models, Specifications and Application

9.13.4 Glooko AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.13.5 Glooko Recent Developments

9.14 Adaptive Biotechnologies

9.14.1 Adaptive Biotechnologies Company Information, Head Office, Market Area and Industry Position

9.14.2 Adaptive Biotechnologies Company Profile and Main Business

9.14.3 Adaptive Biotechnologies AI In Vitro Diagnostic Models, Specifications and Application

9.14.4 Adaptive Biotechnologies AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.14.5 Adaptive Biotechnologies Recent Developments

9.15 Aidoc

9.15.1 Aidoc Company Information, Head Office, Market Area and Industry Position

9.15.2 Aidoc Company Profile and Main Business

9.15.3 Aidoc AI In Vitro Diagnostic Models, Specifications and Application

9.15.4 Aidoc AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.15.5 Aidoc Recent Developments

9.16 Anumana

9.16.1 Anumana Company Information, Head Office, Market Area and Industry Position

9.16.2 Anumana Company Profile and Main Business

9.16.3 Anumana AI In Vitro Diagnostic Models, Specifications and Application

9.16.4 Anumana AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.16.5 Anumana Recent Developments

9.17 ARUP Laboratories

9.17.1 ARUP Laboratories Company Information, Head Office, Market Area and Industry Position

9.17.2 ARUP Laboratories Company Profile and Main Business

9.17.3 ARUP Laboratories AI In Vitro Diagnostic Models, Specifications and Application

9.17.4 ARUP Laboratories AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.17.5 ARUP Laboratories Recent Developments

9.18 K Health

9.18.1 K Health Company Information, Head Office, Market Area and Industry Position

9.18.2 K Health Company Profile and Main Business

9.18.3 K Health AI In Vitro Diagnostic Models, Specifications and Application

9.18.4 K Health AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.18.5 K Health Recent Developments

9.19 Lunit

9.19.1 Lunit Company Information, Head Office, Market Area and Industry Position

9.19.2 Lunit Company Profile and Main Business

9.19.3 Lunit AI In Vitro Diagnostic Models, Specifications and Application

9.19.4 Lunit AI In Vitro Diagnostic Revenue and Gross Margin, 2018-2023

9.19.5 Lunit Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
AI In Vitro Diagnostic Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the AI In Vitro Diagnostic Market trending toward high growth trajectories?
A dynamic process in the AI In Vitro Diagnostic Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Qiagen N.V., Hologic Inc., Sysmex Corporation, Becton, Dickinson and Company, bioMérieux SA, Ortho Clinical Diagnostics, Agilent Technologies, Illumina Inc., Cepheid, Genomic Health, Luminex Corporation, Myriad Genetics, Natera Inc., Adaptive Biotechnologies.
Why are some of the most well-known companies left out of the AI In Vitro Diagnostic Market study?
The AI In Vitro Diagnostic study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.
What are the major applications for AI In Vitro Diagnostic ?
AI In Vitro Diagnostic has a wide range of applications, including and others.
What is the current state of the AI In Vitro Diagnostic Industry, and what is the projected growth trajectory through 2030?
In 2024, the AI In Vitro Diagnostic Market share surpassed USD xx million, and between 2025 and 2030, it will grow at a CAGR of yy%.
Where does the AI In Vitro Diagnostic Industry stands in terms of scaling end-use implementations?
According to the AI In Vitro Diagnostic Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
How does the AI In Vitro Diagnostic Market study reflects the current scenario?
The AI In Vitro Diagnostic study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.